These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38292061)
21. Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types. Khalafallah SA; Eltayeb Ahmed EA; Elnour LS; Mohammed R; Makawi A; Mohamed AK; Balla A; Alamin MF; Alfaki M Cureus; 2024 Aug; 16(8):e68093. PubMed ID: 39347140 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis. Yang L; Cui Y; Sun X; Wang Y Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413 [TBL] [Abstract][Full Text] [Related]
23. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
24. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer. Liu J; Ji C; Wang Y; Zhang C; Zhu H Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261 [TBL] [Abstract][Full Text] [Related]
25. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Yang J; Li H; Hu S; Zhou Y Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157 [TBL] [Abstract][Full Text] [Related]
26. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers. Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192 [TBL] [Abstract][Full Text] [Related]
27. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma. Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J Front Immunol; 2021; 12():788431. PubMed ID: 34970268 [TBL] [Abstract][Full Text] [Related]
28. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival. Taha MY; Mohamed NO; Alhaj LG; Altayeb I; Basheer A; Idrees S; Said AM; Alfaki M Cureus; 2024 Jul; 16(7):e65504. PubMed ID: 39188436 [TBL] [Abstract][Full Text] [Related]
29. m Fang F; Wang P; Huang H; Ye M; Liu X; Li Q BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816 [TBL] [Abstract][Full Text] [Related]
30. System analysis of Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494 [TBL] [Abstract][Full Text] [Related]
31. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Huang L; Irshad S; Sultana U; Ali S; Jamil A; Zubair A; Sultan R; Abdel-Maksoud MA; Mubarak A; Almunqedhi BM; Almanaa TN; Malik A; Alamri A; Kodous AS; Mares M; Zaky MY; Saba Sajjad S; Hameed Y Am J Transl Res; 2024; 16(3):873-888. PubMed ID: 38586106 [TBL] [Abstract][Full Text] [Related]
32. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods. Wu R; Wu C; Zhu B; Li J; Zhao W Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398 [No Abstract] [Full Text] [Related]
33. Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial Carcinoma. Jiang XY; Hu JJ; Wang R; Zhang WY; Jin QQ; Yang YT; Mei J; Hong L; Yao H; Tao F; Li JJ; Liu Y; Zhang L; Chen SX; Chen G; Song Y; Zhou SG Biochem Genet; 2024 Oct; 62(5):3439-3466. PubMed ID: 38108937 [TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types. Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q Front Oncol; 2022; 12():947054. PubMed ID: 36505822 [TBL] [Abstract][Full Text] [Related]
35. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. Wang Y; Ren F; Song Z; Wang X; Ma X J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522 [TBL] [Abstract][Full Text] [Related]
36. RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma. Tang J; Tian X; Min J; Hu M; Hong L Front Oncol; 2022; 12():957472. PubMed ID: 36091104 [TBL] [Abstract][Full Text] [Related]
37. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy. Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma. Wang M; Yue S; Yang Z Sci Rep; 2023 Mar; 13(1):4081. PubMed ID: 36906716 [TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
40. Construction of the novel immune risk scoring system related to CD8 Zhang G; Yin Z; Fang J; Wu A; Chen G; Cao K Cancer Cell Int; 2023 Jun; 23(1):124. PubMed ID: 37349706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]